Qualigen Therapeutics Inc share price logo

Qualigen Therapeutics Inc Share Price

NASDAQ: QLGN

$3.19

+0.15

(+4.93%)

Live

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 18 Nov 2025

Qualigen Therapeutics Inc Stock Performance

as on November 19, 2025 at 7:59 am IST

  • Day's Low

    Day's High

    $2.86
    $3.34
    downward going graph

    10.34%

    Downside

    4.70%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.61
    $8.81
    downward going graph

    49.53%

    Downside

    176.18%

    Upside

    downward going graph

Qualigen Therapeutics Inc share price movements today

Previous Close
$3.04
Open
$2.92
Volume
750.2K
Day's Low - High
$2.86 - $3.34
52 Week Low - High
$1.61 - $8.81

Qualigen Therapeutics Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Qualigen Therapeutics Inc Stock Fundamentals & Key Indicators

Check Qualigen Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Qualigen Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Qualigen Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Qualigen Therapeutics Inc image
Qualigen Therapeutics Inc
BUY$-NANA0.00%
Insmed Incorporated image
Insmed Incorporated
BUY$35.5B365.18%-16.34-210.54%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$43.9B131.81%142.628.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$113.4B109.94%28.932.94%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$81.7B63.66%18.6231.41%

Analyst Recommendation on Qualigen Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Qualigen Therapeutics Inc. Average target price of $5

Qualigen Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Qualigen Therapeutics Inc.

What analysts predicted

36.2%UPSIDE

Target Price

$5

Current Price

$3.19

Analyzed by

7 Analysts

Target

$5.00

Qualigen Therapeutics Inc target price $5, a slight upside of 36.2% compared to current price of $3.19. According to 7 analysts rating.

Qualigen Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
1
7
-
-
-
-
-
2
-
Gross Profit
0
2
0
0
0
0
-
1
0
Operating Income
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-3
-3
-2
-2
-1
-1
0
0
-1
Net Profit Margin
-212.92%
-46.03%
0.00%
0.00%
0.00%
0.00%
0.00%
-38.25%
0.00%

Qualigen Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
9
5
5
4
5
4
5
-
Gross Profit
-7
-16
1
-2
1
0
0
-
Operating Income
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-7
-16
-1
-20
-17
-21
-13
-6
Net Profit Margin
-80.44%
-290.69%
-32.16%
-474.16%
-316.55%
-422.08%
-257.79%
0.00%

Global Institutional Holdings in Qualigen Therapeutics Inc

Funds
Holdings
LLBH Private Wealth Management, LLC
0.59%
Tower Research Capital LLC
0.07%
BlackRock Inc
0.03%
HARBOUR INVESTMENTS, INC.
0.02%
Group One Trading, LP
0%
See all

Qualigen Therapeutics Inc News & Key Events

  • img

    Today's Timeline - 16 November

    Mon, 02:41 AM

    -

    Shareholders approved proposals, confirming Faraday Future as new majority shareholder; renaming and ticker change to AIXC on November 20.

Insights on Qualigen Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, QLGN stock has moved up by 26.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 177.4% return, outperforming this stock by 194.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 933.9% return, outperforming this stock by 1030.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 7.94M → 2.23M (in $), with an average decrease of 71.8% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -855.82K → -2.03M (in $), with an average decrease of 58.9% per quarter

About Qualigen Therapeutics Inc

Qualigen Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing treatments for adult and pediatric cancers. The Company’s business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program (Pan-RAS). Its lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells (such as pancreatic cancer). Its Pan-RAS program, which is at the preclinical stage, consists of a family of rat sarcoma virus (RAS) oncogene protein-protein interaction inhibitor small molecules inhibits or block mutated RAS genes’ proteins from binding to their effector proteins thereby leaving the proteins from the mutated RAS unable to cause further harm. Its QN-302 is in a Phase 1a clinical trial.
OrganisationQualigen Therapeutics Inc
E-voting on sharesClick here to vote

FAQs

What is Qualigen Therapeutics Inc share price today?

Qualigen Therapeutics Inc share price today is $3.19 as on . Qualigen Therapeutics Inc share today touched a day high of $3.34 and a low of $2.86.

What is the 52 week high and 52 week low for Qualigen Therapeutics Inc share?

Qualigen Therapeutics Inc share touched a 52 week high of $8.81 on and a 52 week low of $1.61 on . Qualigen Therapeutics Inc stock price today i.e. is trending at $3.19,which is 63.79% down from its 52 week high and 98.14% up from its 52 week low.

How to invest in Qualigen Therapeutics Inc Stock (QLGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Qualigen Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Qualigen Therapeutics Inc Shares that will get you 0.4702 shares as per Qualigen Therapeutics Inc share price of $3.19 per share as on November 19, 2025 at 2:29 am IST.

What is the minimum amount required to buy Qualigen Therapeutics Inc Stock (QLGN) from India?

Indian investors can start investing in Qualigen Therapeutics Inc (QLGN) shares with as little as ₹93.116 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹931.16 in Qualigen Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Qualigen Therapeutics Inc share’s latest price of $3.19 as on November 19, 2025 at 2:29 am IST, you will get 3.1348 shares of Qualigen Therapeutics Inc. Learn more about fractional shares .